共 5 条
[2]
Thrombolysis With 0.6 mg/kg Intravenous Alteplase for Acute Ischemic Stroke in Routine Clinical Practice: The Japan post-Marketing Alteplase Registration Study (J-MARS)[J] . Jyoji Nakagawara,Kazuo Minematsu,Yasushi Okada,Norio Tanahashi,Shinji Nagahiro,Etsuro Mori,Yukito Shinohara,Takenori Yamaguchi.Stroke . 2010 (9)
[3]
Effects of 0.6 mg/kg Intravenous Alteplase on Vascular and Clinical Outcomes in Middle Cerebral Artery Occlusion: Japan Alteplase Clinical Trial II (J-ACT II)[J] . Etsuro Mori,Kazuo Minematsu,Jyoji Nakagawara,Takenori Yamaguchi,Makoto Sasaki,Teruyuki Hirano.Stroke . 2010 (3)
[4]
Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study[J] . Nils Wahlgren,Niaz Ahmed,Antoni Dávalos,Gary A Ford,Martin Grond,Werner Hacke,Michael G Hennerici,Markku Kaste,Sonja Kuelkens,Vincent Larrue,Kennedy R Lees,Risto O Roine,Lauri Soinne,Danilo Toni,Geert Vanhooren.The Lancet . 2007 (9558)
[5]
R1 – Systemic thrombolysis in German stroke units[J] . J. Schenkel,C. Weimar,T. Knoll,R. L. Haberl,O. Busse,G. F. Hamann,H.-C. Koennecke,H.-C. Diener.Journal of Neurology . 2003 (3)